NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,358,000 | +6.6% | 79,921 | +4.1% | 0.00% | 0.0% |
| Q3 2020 | $1,274,000 | -24.7% | 76,804 | +5.2% | 0.00% | -33.3% |
| Q2 2020 | $1,692,000 | +59.5% | 73,038 | +22.9% | 0.01% | +20.0% |
| Q1 2020 | $1,061,000 | +9.0% | 59,405 | +31.8% | 0.01% | +66.7% |
| Q4 2019 | $973,000 | +42.9% | 45,082 | +20.6% | 0.00% | 0.0% |
| Q3 2019 | $681,000 | -56.5% | 37,380 | -15.2% | 0.00% | -50.0% |
| Q2 2019 | $1,567,000 | +14.5% | 44,069 | +8.3% | 0.01% | 0.0% |
| Q1 2019 | $1,368,000 | +13.2% | 40,709 | +10.8% | 0.01% | 0.0% |
| Q4 2018 | $1,208,000 | -47.7% | 36,730 | -3.1% | 0.01% | -40.0% |
| Q3 2018 | $2,310,000 | +17.7% | 37,898 | -5.7% | 0.01% | +11.1% |
| Q2 2018 | $1,963,000 | -65.8% | 40,194 | -25.5% | 0.01% | -69.0% |
| Q1 2018 | $5,736,000 | +92.7% | 53,985 | +8.3% | 0.03% | +93.3% |
| Q4 2017 | $2,976,000 | +185.1% | 49,830 | +14.6% | 0.02% | +150.0% |
| Q3 2017 | $1,044,000 | +23.3% | 43,485 | +0.3% | 0.01% | +20.0% |
| Q2 2017 | $847,000 | -7.6% | 43,347 | +11.0% | 0.01% | -16.7% |
| Q1 2017 | $917,000 | +100.7% | 39,057 | +4.7% | 0.01% | +100.0% |
| Q4 2016 | $457,000 | -36.0% | 37,305 | -10.2% | 0.00% | -40.0% |
| Q3 2016 | $714,000 | +85.9% | 41,553 | +53.9% | 0.01% | +66.7% |
| Q2 2016 | $384,000 | +0.5% | 27,004 | -2.9% | 0.00% | 0.0% |
| Q1 2016 | $382,000 | -22.8% | 27,814 | -5.4% | 0.00% | -40.0% |
| Q4 2015 | $495,000 | +121.0% | 29,395 | +43.5% | 0.01% | +150.0% |
| Q3 2015 | $224,000 | +28.0% | 20,483 | +46.4% | 0.00% | 0.0% |
| Q2 2015 | $175,000 | – | 13,988 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |